← Open Payments lookup

KATIE WILLIAMSON: Open Payments

NPI 1114654035 · ORANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$353 in 16 payments from 9 companies in 2025. Trend: 2023 $583 · 2024 $288 · 2025 $353

Food & beverage: $353
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$93
Gilead Sciences, Inc.2$87
Axsome Therapeutics, Inc.2$41
ABBVIE INC.2$33
Supernus Pharmaceuticals, Inc.1$24
SUN PHARMACEUTICAL INDUSTRIES INC.1$23
Lilly USA, LLC1$22
Kowa Pharmaceuticals America, Inc.1$17
Exact Sciences Corporation1$14

Products named: FARXIGA, Yeztugo, Auvelity, Qelbree, Winlevi, MOUNJARO, QULIPTA, ZORYVE.

Industry payments across TX — which companies pay providers there.